BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37007608)

  • 1. Targeted adenovirus-mediated transduction of human T cells
    Freitag PC; Kaulfuss M; Flühler L; Mietz J; Weiss F; Brücher D; Kolibius J; Hartmann KP; Smith SN; Münz C; Chijioke O; Plückthun A
    Mol Ther Methods Clin Dev; 2023 Jun; 29():120-132. PubMed ID: 37007608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modular Adapters Utilizing Binders of Different Molecular Types Expand Cell-Targeting Options for Adenovirus Gene Delivery.
    Freitag PC; Brandl F; Brücher D; Weiss F; Dreier B; Plückthun A
    Bioconjug Chem; 2022 Sep; 33(9):1595-1601. PubMed ID: 35944553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering.
    Michels KR; Sheih A; Hernandez SA; Brandes AH; Parrilla D; Irwin B; Perez AM; Ting HA; Nicolai CJ; Gervascio T; Shin S; Pankau MD; Muhonen M; Freeman J; Gould S; Getto R; Larson RP; Ryu BY; Scharenberg AM; Sullivan AM; Green S
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36918221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.
    Tatsis N; Blejer A; Lasaro MO; Hensley SE; Cun A; Tesema L; Li Y; Gao GP; Xiang ZQ; Zhou D; Wilson JM; Ertl HC
    Mol Ther; 2007 Mar; 15(3):608-17. PubMed ID: 17228314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.
    Lewis TB; Glasgow JN; Glandon AM; Curiel DT; Standaert DG
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5.
    Coughlan L; Vallath S; Gros A; Giménez-Alejandre M; Van Rooijen N; Thomas GJ; Baker AH; Cascalló M; Alemany R; Hart IR
    Hum Gene Ther; 2012 Sep; 23(9):960-79. PubMed ID: 22708837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.
    Ballmann MZ; Raus S; Engelhart R; Kaján GL; Beqqali A; Hadoke PWF; van der Zalm C; Papp T; John L; Khan S; Boedhoe S; Danskog K; Frängsmyr L; Custers J; Bakker WAM; van der Schaar HM; Arnberg N; Lemckert AAC; Havenga M; Baker AH
    J Virol; 2021 Oct; 95(22):e0038721. PubMed ID: 34469243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a targeted gene vector platform based on simian adenovirus serotype 24.
    Belousova N; Mikheeva G; Xiong C; Soghomonian S; Young D; Le Roux L; Naff K; Bidaut L; Wei W; Li C; Gelovani J; Krasnykh V
    J Virol; 2010 Oct; 84(19):10087-101. PubMed ID: 20631120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction
    Lopez-Gordo E; Doszpoly A; Duffy MR; Coughlan L; Bradshaw AC; White KM; Denby L; Nicklin SA; Baker AH
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric adenoviral vector Ad5F35L containing the Ad5 natural long-shaft exhibits efficient gene transfer into human T lymphocytes.
    Zhang WF; Wu FL; Shao HW; Wang T; Huang XT; Li WL; Shen H; Huang SL
    J Virol Methods; 2013 Dec; 194(1-2):52-9. PubMed ID: 23933078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
    Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
    J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy.
    Thirion C; Lochmüller H; Ruzsics Z; Boelhauve M; König C; Thedieck C; Kutik S; Geiger C; Kochanek S; Volpers C; Burgert HG
    Hum Gene Ther; 2006 Feb; 17(2):193-205. PubMed ID: 16454653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
    Tolmachov OE
    Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gene delivery into hCD34+ cells in a humanized mouse model.
    Frecha C; Fusil F; Cosset FL; Verhoeyen E
    Methods Mol Biol; 2011; 737():367-90. PubMed ID: 21590405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized adenovirus gene delivery using antiviral IgG complexation.
    Levy RJ; Song C; Tallapragada S; DeFelice S; Hinson JT; Vyavahare N; Connolly J; Ryan K; Li Q
    Gene Ther; 2001 May; 8(9):659-67. PubMed ID: 11406760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of adenoviral transduction with polycationic liposomes in vivo.
    Lee SG; Yoon SJ; Kim CD; Kim K; Lim DS; Yeom YI; Sung MW; Heo DS; Kim NK
    Cancer Gene Ther; 2000 Oct; 7(10):1329-35. PubMed ID: 11059690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo.
    van Geer MA; Bakker CT; Koizumi N; Mizuguchi H; Wesseling JG; Oude Elferink RP; Bosma PJ
    World J Gastroenterol; 2009 Jun; 15(22):2754-62. PubMed ID: 19522026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of peritoneal tumor-targeting vector by in vivo screening with a random peptide-displaying adenovirus library.
    Nishimoto T; Yamamoto Y; Yoshida K; Goto N; Ohnami S; Aoki K
    PLoS One; 2012; 7(9):e45550. PubMed ID: 23029088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.